Jean Stephenne, President/General Manager, GlaxoSmithKline Biologicals
THE LIBRARY: EBOOK
Special Report | The Changing Landscape of Phase IV Research
Industry spending on post-authorization studies belies the rapid changes occurring in Phase IV research, driven by an the demand for evidence of safety and effectiveness. Download this Special Report to learn how Phase IV research continues to transform.
Latest Commentary
Combating HIV: The future of therapeutic vaccines
10 promising therapeutic vaccines in 2012
The 20 top-selling vaccines in H1 2012
GeoVax: Meeting the HIV vaccine challenge
Wishing you a happy HIV Vaccine Awareness Day
more
EVENTS
- BioBasics: Biotech for the Non-ScientistOctober 23-24 — Boston, MA
- Drug Development Boot Camp - November 19-20, 2014, Boston, MANovember 19-20, 2014 — Boston, MA — Hosted by Harvard University OTD and Speid & Associates, Inc.
- Drug Development PrimerDecember 4-5 — Boston, MA
Press Releases
- Amgen Announces 2014 Fourth Quarter Dividend
- Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors
- Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors
- Cardiorentis AG and Roche Announce Collaboration to Establish Therapeutic Impact of Ularitide
- Pharmacyclics Enters Into Agreement with Roche to Evaluate IMBRUVICA® and GAZYVA® in Lymphoma and Leukemia
- More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.